Phase II trial of the anti-GD2 monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Bone Marrow Neoplasms
  • Bone Neoplasms
  • Gangliosides
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Immunoglobulin G
  • Neuroblastoma

abstract

  • 3F8/GM-CSF is well tolerated and shows promise for treatment of minimal residual NB in BM.

publication date

  • November 15, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11709561

Additional Document Info

start page

  • 4189

end page

  • 94

volume

  • 19

number

  • 22